23 December 2025
Latham & Watkins Advises on Fulgent Genetics’ Acquisition of Bako Diagnostics and StrataDX
Advising firms
Deal team
22 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| David Allinson Lead | Latham & Watkins LLP | Partner | corporate | New York |
| Edmond Parhami Lead | Latham & Watkins LLP | Partner | corporate | New York |
| Josh Barkow | Latham & Watkins LLP | Associate | corporate | Not stated |
| Samyung Han | Latham & Watkins LLP | Associate | corporate | Not stated |
| Matthew Dewitz | Latham & Watkins LLP | Partner | tax | New York |
| Jack Santoro | Latham & Watkins LLP | Associate | tax | Not stated |
| Bradd Williamson | Latham & Watkins LLP | Partner | executive compensation, employment, and benefits | New York |
| Max Raskin | Latham & Watkins LLP | Partner | executive compensation, employment, and benefits | New York |
| Anne Bracaglia | Latham & Watkins LLP | Associate | executive compensation, employment, and benefits | Not stated |
| Seokwon Lee | Latham & Watkins LLP | Associate | executive compensation, employment, and benefits | Not stated |
| Nineveh Alkhas | Latham & Watkins LLP | Partner | labor | Chicago |
| Jocelyn Wexler | Latham & Watkins LLP | Associate | labor | Not stated |
| Jason Caron | Latham & Watkins LLP | Partner | healthcare | Washington, D.C. |
| Yanyan Zhou | Latham & Watkins LLP | Associate | healthcare | Not stated |
| Danny Machado | Latham & Watkins LLP | Associate | healthcare | Not stated |
| Deborah Hinck | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Susana Santos | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Zachary Shufro | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Victoria Allen | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Heather Deixler | Latham & Watkins LLP | Partner | data privacy and cybersecurity | Bay Area |
| Chad Leiper | Latham & Watkins LLP | Associate | data privacy and cybersecurity | Houston |
| Harrison White | Latham & Watkins LLP | Partner | insurance | Los Angeles |
Stated terms
- Stated value
- USD 55.5m (approximately US$55.5 million)
- What the figure measures
- Total transaction value
- Client
- Fulgent Genetics, Inc.Buy-side
- Counterparties
- Consonance Capital Partners (Other)
Bako Diagnostics (Sell-side)
StrataDx (Sell-side)